Olema Pharmaceuticals (OLMA)
(Delayed Data from NSDQ)
$12.30 USD
-0.20 (-1.60%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $12.31 +0.01 (0.08%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.54 |
EPS Last Quarter | -0.56 |
Last EPS Surprise | -5.66% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.30 |
Next Year | -2.44 |
EPS (TTM) | -2.02 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.54 | -0.56 | -2.30 | -2.44 |
# of Estimates | 7 | 6 | 6 | 5 |
Most Recent Consensus | -0.50 | -0.53 | -2.15 | -2.43 |
High Estimate | -0.47 | -0.52 | -2.11 | -2.02 |
Low Estimate | -0.62 | -0.62 | -2.50 | -2.85 |
Year ago EPS | -0.49 | -0.48 | -2.14 | -2.30 |
Year over Year Growth Est. | -10.20% | -16.67% | -7.48% | -6.03% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.54 | -0.56 | -2.30 | -2.44 |
7 Days Ago | -0.54 | -0.56 | -2.30 | -2.44 |
30 Days Ago | -0.54 | -0.56 | -2.30 | -2.44 |
60 Days Ago | -0.58 | -0.61 | -2.45 | -2.65 |
90 Days Ago | -0.55 | -0.60 | -2.34 | -2.55 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.54 | -0.56 | -2.30 | -2.44 |
Zacks Consensus Estimate | -0.54 | -0.56 | -2.30 | -2.44 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.56 | -0.49 | -0.48 | -0.49 | NA |
Estimate | -0.53 | -0.49 | -0.51 | -0.73 | NA |
Difference | -0.03 | 0.00 | 0.03 | 0.24 | 0.06 |
Surprise | -5.66% | 0.00% | 5.88% | 32.88% | 8.28% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more